Delivery Order SPE2DB22D3501-SPE2DB23FWQ80
Award Date 7/28/23
Potential Completion Date 7/31/23
Potential Value $67
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $714 delivery order to Amerisourcebergen Drug Corporation for doxorubicin hydrochloride injection. The product will be delivered from the contractor's facility in Conshohocken, Pennsylvania to an unknown customer by July 14, 2023. The firm fixed price order was issued under an unspecified multiple award contract vehicle. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the United...
- The Defense Logistics Agency awarded a $259,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/100 ml vials of doxorubicin. As part of DLA's pharmaceutical supply chain support to the Department of Defense, this order will provide 100 ml vials of the chemotherapy drug to Conshohocken, Pennsylvania for use by August 17, 2023 under the agency's Prime Vendor program. Amerisourcebergen will deliver the products as the prime contractor, with no subcontractors...
- The Defense Logistics Agency awarded a $61,490 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/100 ml vials of doxorubicin. The single-day contract has a period of performance from June 26-27, 2023, with all work taking place in Conshohocken, Pennsylvania. DLA handles medical commodity procurement for the Department of Defense, and this appears to be a small order of chemotherapy drugs to support DOD treatment programs. No subcontractors or set-aside designations...
- The Defense Logistics Agency awarded a $142,790 delivery order to Amerisourcebergen Drug Corporation for 4561498522 Doxorubicin 200 mg/100 ml vials. The firm fixed price order is for 100 ml of the chemotherapy drug to be delivered from Amerisourcebergen's Conshohocken, Pennsylvania facility by July 17, 2023 in support of DLA programs. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order from its parent company Amerisourcebergen Corporation...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $339,150 delivery order by the Defense Logistics Agency to provide Doxorubicin hydrochloride injection, 20 mg/10 mL vials. The products will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown customer by August 29, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the Department of Defense's...
- The Defense Logistics Agency awarded a $245,700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg/25 ml vials of doxorubicin. The single award was issued under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a three day period concluding July 31, 2023. No subcontractors or set aside designations were identified. This order...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.90 to AmerisourceBergen Drug Corp for Doxorubicin 200 mg/100 mL vials on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single-line pharmaceutical procurement executed under the company's larger contract vehicle with DLA. The product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxorubicin 200 mg/100 mL vials totaling $1,928.51 with a firm fixed price arrangement. The contract, which is non-set-aside and competitively awarded, was finalized on July 22, 2025, with an ultimate completion date of July 23, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $51,940 delivery order by the Defense Logistics Agency to provide 100 ml vials of the chemotherapy drug doxorubicin. The firm fixed price order is for delivery of the pharmaceutical to a location in Conshohocken, Pennsylvania between August 11-14, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency is a combat logistics support agency within the...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $2,371.47 from the Defense Logistics Agency Troop Support Medical to supply 10mL vials of Doxorubicin Liposome, a chemotherapy medication, for delivery by December 11, 2023. This order was awarded against an indefinite delivery contract held by Amerisourcebergen Drug Corp with no set-aside designation specified. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, to supply...